Aspirin has been effective for acute migraines both as a solitary modality and in combination with other drugs, and thus has clinical value in treatment and prophylaxis of the migraines overall.
Gene therapy shows promise in the management of inherited peripheral neuropathy and the complex array of symptoms that patients experience. Gene therapy holds promise in the management of peripheral neuropathies and in significant improvement of quality of life for patients.
Deep brain stimulation offers a potential treatment for chronic pain, either in part or in full, to enhance patients overall quality of life.
Research has revealed that the SARS-CoV-2 viral infection may have neurological manifestations, with critical implications for clinical practice.
